Close
4

Bora CDMO Bora CDMO

X

Company profile for AffyImmune Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
AffyImmune is a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer. AffyImmune’s core focus is on developing CAR T cells effective in treating solid tumors, which account for 90% of all cancer fatalities. Our Phase I clinical trial of our lead compound in patients with anaplastic or refractory thyroid cance...
AffyImmune is a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer. AffyImmune’s core focus is on developing CAR T cells effective in treating solid tumors, which account for 90% of all cancer fatalities. Our Phase I clinical trial of our lead compound in patients with anaplastic or refractory thyroid cancer is now enrolling patients. AffyImmune was founded in 2016 on the basis of research and technologies developed at Harvard Medical School and Weill Cornell Medical College.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
AffyImmune Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
22 Strathmore Road Natick, MA 01760 (617) 699-1965
Telephone
Telephone
(617) 699-1965
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY